The role of L-carnitine on a restricted number of myeloid leukemia progenitor cells: Generation of atypical cell types

Haematologia

Volumn 32, Issue 4, 2002, Pages 341-353

  Vassiliadis, Simon ^a   Evangeliou, A ^a   Basta, E ^a   Dionyssopoulou, E ^a   Dimitriou, H ^a   Stiakaki, E ^b   Kalmanti, M ^b   Athanassakis, I ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

Cytopoiesis; Differentiation; HL 60; Interferon ; L carnitine; Nerve cells; Plasticity; Progenitor cells

Indexed keywords

CARNITINE; CD14 ANTIGEN; CELL MARKER; HLA DR ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; NERVE GROWTH FACTOR ANTIBODY; NERVE GROWTH FACTOR RECEPTOR; NEUROFILAMENT PROTEIN;

ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL ASSAY; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SPECIFICITY; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MONOCYTE; MYELOID LEUKEMIA; NEUROFILAMENT; NEUTROPHIL; PLASTICITY; PROMYELOCYTE;

ANTIGENS, CD14; CARNITINE; CELL DIFFERENTIATION; CELL DIVISION; HL-60 CELLS; HLA-DR ANTIGENS; HUMANS; LIPID METABOLISM; MYELOID PROGENITOR CELLS; TUMOR STEM CELLS;

EID: 0038047687     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Collins, S. J., Gallo, R. C., Gallangher, R. E., Continuous growth and differentiation of human myeloid leukemia cells in suspension culture, Nature 270, 347 (1977).
2. Collins, S. J., Ruscetti, F. W, Gallangher, R. E., Gallo, R. C., Terminal differentiation of human promyelocytic leukemia cells induced by DMSO and other polar compounds, Proc. Natl. Acad. Sci. USA 75, 2458 (1978).
3. Collins, S. J., The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation and cellular oncogene expression, Blood 70, 1233 (1987).
4. Vassiliadis, S., Guilbert, L. J., Kyrpides, N., Papamatheakis, J., Different molecular mechanisms lead to same endpoints with different function: TNF-α induces non-functional CSF-1 receptors on HL-60 cells in contrast to interferon-γ, J. Recept. Res. 12, 59 (1992).
5. Vassiliadis, S., Guilbert, L. J., Immune interferon induces early and late events in the differentiation of HL-60 that are part of the same maturation program, Exp. Haematol. 19, 250 (1991).
6. Vassiliadis, S., Stravopodis, D., Kyrpides, N., Grigoriou, M., Papamatheakis, J., One and two-level regulation patterns affecting NF-kB mRNA and nuclear NF-kB activity after treatment with TNF-α, IFN-γ and IL-4, Eur. Cytokine Netw. 4, 25 (1993).
7. Vassiliadis, S., Papamatheakis, J., The p21ras protein as an intermediate signaling molecule in the IL-1-induced expression on normal and leukemic human myeloid cells, Cell Immunol. 142, 426 (1992).
8. Vassiliadis, S., Analysis of signals leading to differentiation of immature HL-60 after administration of IL-4, Med. Inflamm. 4, 415 (1994).
9. Vassiliadis, S., Papadogeorgakis, S., Athanassakis, I., Specific nuclear binding of anti cdc2 on p34cdc2 positive autonomously grown human leukemia cells induces differentiation, Leuk. Res. 19, 535 (1995).
10. Vassiliadis, S., Guided myeloid leukemia cell differentiation by blocking a specific cell cycle stage, Int. J. Hematol. 63, 235 (1996).
11. Palucka, K. A., Taquet, N., Sanchez-Chapuis, F., Gluckman, J. C., Dendritic cells as the terminal stage of monocyte differentiation, J. Immunol. 160, 4587 (1998).
12. Naito, M., Kudo, I., Nakagawa, Y., Waku, K., Nojiri, H., Saito, M., Inoue, K., Lipids of human promyelocytic leukemia cell HL-60: increasing levels of ether-linked phospholipids during retinoic acid-induced differentiation, J. Biochem. 102, 155 (1987).
13. Ishiguro, S., Takahashi, N., Nemoto, K., Negishi, M., Ichikawa, A., Potentiation of retinoic acid-induced differentiation of HL-60 cells by prostaglandin EP2 receptor, Prostaglandins Lipid Mediat. 56, 145 (1998).
14. Colquhoun, A., de Mello, F. E., Curi, R., Regulation of tumor cell fatty acid oxidation by n-6 polyunsaturated fatty acids, Biochem. Mol. Biol. Int. 44, 143 (1998).
15. Bremer, J., Carnitine, metabolism and functions, Physiol. Rev. 63, 1420 (1984).
16. Carter, L., Abney, T. O., Lapp, D. F., Biosynthes is and metabolism of carnitine, J. Child Neurol. 10 (Suppl. 1), 2S3 (1995) (Abstract).
17. Bremer, J., The role of carnitine in intracellular metabolism, J. Clin. Chem. Clin. Biochem. 28, 297 (1990).
18. Sachan, D. S., Dodson, W. L., The serum carnitine status of cancer patients, J. Am. Coll. Nutr. 6,145 (1987).
19. Parnetti, L., Gaiti, A., Mecocci, P., Cadini, D., Senin, U., Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of the Alzheimer type, Eur. J. Clin. Pharmacol. 42, 89 (1992).
20. Stumpf, D. A., Mitochondrial disorders, Rinsho Shinkeigaku (Tokyo) 23, 1046 (1983).
21. Bohles, H., Evangeliou, A., Bervoets, K., Cadini, D., Senin, U., Carnitine esters in metabolic disease, Eur. J. Pediatr. 153, 57 (1994).
22. Ramacci, M. T., De Rossi, M., Lucreziotti, M. R., Mione, M. C., Amenta, F., Effect of long-term treatment with acetyl-L-carnitine on structural changes of ageing rat brain, Drugs Exp. Clin. Res. 14, 593 (1998).
23. Makar, T. K., Cooper, A. J., Tofel-Grehl, B., Thaler, H. T., Blass, J. P., Carnitine, carnitine acyltransferase, and glutathione in Alzheimer brain, Neurochem. Res. 6, 705 (1995).
24. Ramsay, R. R., Tubbs, P. K., The mechanism of fatty acid uptake by heart mitochondria: an acylcarnitine-carnitine exchange, FEBS Lett. 5, 21 (1975).
25. Pande, S. V., A mitochondrial carnitine acylcarnitine translocase system, Proc. Natl. Acad. Sci. USA 72, 883 (1975).
26. Phelps, P. E., Alijani, A., Tran, T. S., Ventrally located commissural neurons express the GABAergic phenotype in developing rat spinal cord, J. Comp. Neurol. 409, 285 (1999).
27. Serafini, T., Colamarino, S. A., Leonardo, E. D., Wang, H., Beddington, R., Skarnes, W. C., Tessier-Lavigne, M., Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system, Cell 87,1001 (1996).
28. Harada, A., Takeuchi, K., Dohmae, N., Takio, K., Uenaka, T., Aoki, J., Inoue, K., Umeda, M., A monoclonal antibody, 3A10, recognizes a specific amino acid sequence present on a series of developmentally expressed brain proteins, J. Biochem. 125, 443 (1999).
29. Franke, F. E., Schachenmayr, W., Osborn, M., Altmannsberger, M., Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors, Am. J. Pathol. 139, 67 (1991).
30. Rao, M. S., Anderson, D. J., Immortalization and controlled in vitro differentiation of murine multipotent neural crest stem cells, J. Neurobiol. 32, 722 (1997).
31. Young, H. M., Ciampoli, D., Hsuan, J., Canty, A. J., Expression of Ret-, p75 (NTR)-, Phox2a-, Phox2b-, and tyrosine hydrolase-immunoreactivity by undifferentiated neural crest-derived cells and different classes of enteric neurons in the embryonic mouse gut, Dev. Dyn. 216, 137 (1999).
32. Willingham, M. C., Immunocytochemical methods: Useful and informative tools for screening hybridomas and evaluating antigen expression, Focus 2, 62 (1990).
33. McGarry, J. D., Foster, D. W., An improved and simplified radioisotopic assay for the determination of free and esterified carnitine, J. Lipid Res. 17, 277 (1976).
34. Debus, E., Weber, K., Osborn, M., Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides, Differentiation 25, 193 (1983).
35. Lee, C. K., Kim, J. K., Kim, Y., Lee, M. K., Kim, K., Kang, J. K., Hofmeister, R., Durum, S. K., Han, S. S., Generation of macrophages from early T progenitors in vitro, J. Immunol. 166, 5964 (2001).
36. Manabe, N., Kawaguchi, H., Chikuda, H., Miyaura, C., Inada, M., Nagai, R., Nebeshima, Y., Nakamura, K., Sinclair, A. M., Scheuermann, R. H., Kuro-o, M., Connection between B lymphocytes and osteoclast differentiation pathways, J. Immunol. 167, 2625 (2001).
37. Graf, T., Differentiation plasticity of hematopoietic stem cells, Blood 99, 3089 (2002).